![David Campbell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Campbell
Président chez
iQur Ltd.
Fortune : 3 $ au 31/12/2025
Profil
David Bruce Campbell is currently the Non-Executive Chairman at iQur Ltd. and the Non-Executive Director at Synairgen Plc.
He previously held positions as Chairman at Drug Information Association, Non-Executive Director at Proximagen Group Plc, Director at Modern Biosciences Ltd., Non-Executive Director at BenevolentAI Cambridge Ltd., Scientific Director at Servier Laboratories Ltd., Senior Vice President-International Development at Neurocrine Biosciences, Inc., and Chief Scientific Officer at IP Group Plc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SYNAIRGEN PLC 0,03% | 31/12/2024 | 331 554 ( 0,03% ) | 3 $ | 31/12/2025 |
Postes actifs de David Campbell
| Sociétés | Poste | Début |
|---|---|---|
iQur Ltd.
 iQur Ltd. BiotechnologyHealth Technology Develops vaccines | Président | 01/01/2005 |
Anciens postes connus de David Campbell
| Sociétés | Poste | Fin |
|---|---|---|
| SYNAIRGEN PLC | Directeur/Membre du Conseil | 16/01/2025 |
Proximagen Group Ltd.
 Proximagen Group Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics designed for the treatment of central nervous system diseases | Directeur/Membre du Conseil | 29/01/2010 |
Istesso Therapeutics Ltd.
 Istesso Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Servier Laboratories Ltd.
 Servier Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Directeur Technique/Scientifique/R&D | - |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Synairgen Plc
 Synairgen Plc Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for respiratory disorders | Health Technology |
Proximagen Group Ltd.
Proximagen Group Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics designed for the treatment of central nervous system diseases | Health Technology |
Istesso Therapeutics Ltd.
Istesso Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
IP Group Plc
 IP Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as an intellectual property commercialization and venture capital fund management company | Commercial Services |
BenevolentAI Cambridge Ltd.
 BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to pharmaceutical companies in the areas of Parkinsons disease and other neurodegenerative disorders | Commercial Services |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Commercial Services |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Servier Laboratories Ltd.
Servier Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
